Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-434069
Filing Date
2013-11-08
Accepted
2013-11-08 07:58:52
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d554009d10q.htm 10-Q 610668
2 EX-31.1 d554009dex311.htm EX-31.1 8337
3 EX-31.2 d554009dex312.htm EX-31.2 8377
4 EX-32.1 d554009dex321.htm EX-32.1 4292
5 EX-32.2 d554009dex322.htm EX-32.2 4431
  Complete submission text file 0001193125-13-434069.txt   4463045

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgdo-20130930.xml EX-101.INS 541154
7 XBRL TAXONOMY EXTENSION SCHEMA rgdo-20130930.xsd EX-101.SCH 44016
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgdo-20130930_cal.xml EX-101.CAL 58422
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgdo-20130930_def.xml EX-101.DEF 148482
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgdo-20130930_lab.xml EX-101.LAB 380892
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgdo-20130930_pre.xml EX-101.PRE 257750
Mailing Address 120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 00000
Business Address 120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 00000 908.580.2111
Regado Biosciences Inc (Filer) CIK: 0001311596 (see all company filings)

EIN.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35953 | Film No.: 131202564
SIC: 2834 Pharmaceutical Preparations